Patricia M. LoRusso, DO
Associate Director of Innovative Medicine, Professor of Medicine
Yale Cancer Center
New Haven, Connecticut
Patricia M. LoRusso, DO, is the associate director for innovative medicine at Yale University. She is also the co-leader of the Stand Up To Cancer (SU2C)/Melanoma Research Alliance (MRA)-funded Melanoma Dream Team.
Dr. LoRusso serves as co-chair of the NCI Cancer Therapy Evaluation Program (CTEP) Investigational Drug Steering Committee. She has also served on the education and scientific committees of the American Society of Clinical Oncology (ASCO), the scientific committee of the American Association for Cancer Research (AACR), and as a parent member of the NCI’s Quick Trials Clinical Subcommittee. She has served either ad hoc or as an appointed member on multiple study sections, including Subcommittee D of the Program Projects Grants, and Small Business Innovation Research (SBIR) and Department of Defense (DOD) study sections. She has reviewed for Komen Promise grants, numerous SPORE and P01 study sections and translational research grants.
In 1999, Dr. LoRusso was awarded the Hero of Breast Cancer Award and in 2004 the Bennett J. Cohen Educational Leadership Award for Medical Research. She received the Marygrove College Distinguished Alumni Award and was named one of Crain’s Detroit Business Health Care Heroes. She was also recognized with the 2008 Michaele C. Christian Oncology Drug Development Award and Lectureship from NCI CTEP. In 2013, she received the Hope on the Hill Award for her service to the patients in the state of Michigan.